Identification and characterization of complement C3 receptors on human astrocytes

Journal of Immunology

Volumn 156, Issue 6, 1996, Pages 2247-2255

  Gasque, Philippe ^a   Chan, Philippe ^b   Mauger, Claire ^b   Schouft, Marie Thérèse ^b   Singhrao, Sim ^a   Dierich, Manfred P ^c   Morgan, B Paul ^a   Fontaine, Marc ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b INSERM   (France)

^c UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3 RECEPTOR;

ARTICLE; ASTROCYTE; CELL LYSATE; COMPLEMENT ACTIVATION; FETUS; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INFLAMMATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ASTROCYTES; BASE SEQUENCE; CELL LINE; COMPLEMENT C3; COMPLEMENT C3D; FETUS; HERPESVIRUS 4, HUMAN; HUMANS; LIGANDS; MACROPHAGE-1 ANTIGEN; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RECEPTORS, COMPLEMENT; RECEPTORS, COMPLEMENT 3B; RECEPTORS, COMPLEMENT 3D;

EID: 0029979527     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Fabry, Z., C. S. Raine, and M. N. Hart. 1994. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol. Today 15:218.
2. Casque, P., N. Julen, A. Ischenko, C. Picot, C. Mauger, C. Chauzy, J Ripoche, and M. Fontaine. 1992. Expression of complement components of the alternative pathway by glioma cell lines. J. Immunol. 149:1381.
3. Gasque, P., A. Ischenko, J. Legoedec, C Mauger, M. T. Schouft, and M Fontaine. 1993 Expression of the complement classical pathway by human glioma in culture. J. Biol. Chem 268:25068.
4. Gasque, P., M. Fontaine, and B. P. Morgan. 1995 Complement expression in human brain biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J. Immunol. 154:4726.
5. Wren, D. R., and M. Noble 1989 Oligodendrocytes and oligodendrocyte/type 2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody Proc Natl Acad Sci. USA 86:9025
6. Rogers, J., N. R. Cooper, S. Webster, J Schulz, P. L. McGeer, S. D. Styren, W. H. Civin, L Brachova, B Bradt, P. Ward, and I. Lieberburg. 1992 Complement activation by β-amyloid in Alzheimer disease Proc. Natl. Acad. Sci. USA 89:10016.
7. Krych, M., J. P. Atkinson, and V. M. Holers. 1992. Complement receptors. Curr. Opin. Immunol. 4:8
8. Fingeroth, J. D., J J. Weis, T. F. Tedder, J. L Strominger, P. A. Biro, and D. T. Fearon 1984. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. USA 81:4510.
9. Tanner, J., J. Weis, D. T. Fearon, Y. Whang, and E. Kieff. 1987. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell 50.203
10. Boyer, V., C. Desgranges, M A. Trabaud, E. Fischer, and M D. Kazatchkine. 1991. Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion. J. Exp. Med. 173:1151.
11. Marschang, P., C. F Ebenbichler, and M. P. Dierich. 1994. HIV and complement: role of the complement system in HIV infection Int Arch. Allergy Immunol 103:113.
12. Liebowitz, D. N. 1995 Epstein-Barr virus: an old dog with new tricks N Engl. J. Med. 332:55.
13. Suzushima, H , N. Asou, T. Fujimoto, S Nishimura, T. Okubo, H Yamazaki, M. Osato, M. Matsuoka, A Tsukamoto, K. Takai, F. Kawano, and K Takatsuki. 1995. Lack of the expression of EBNA-2 and LMP-1 in T cell neoplasms possessing Epstein-Barr virus. Biood 85.480.
14. Ahernm, J. M., and D. T. Fearon. 1989. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv. Immunol. 46:183.
15. Fingeroth, J. D., M. L. Clabby, and J D. Strominger. 1988. Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21). J Virol 62:1442.
16. Fischer, E., C. Delibrias, and M D Kazatchkine 1991. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J. Immunol. 146:865.
17. Young, L. S., C. W. Dawson, K. W Brown, and A B. Rickinson. 1989. Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes Int J. Cancer 43:786.
18. Birkenbach, M., X. Tong, L E. Bradbury, T. F. Tedder, and E. Kieff. 1992. Characterization of an Epstein-Barr virus receptor on human epithelial cells. J Exp. Med. 176.1405
19. McClain, K. L., C T. Leach, H. B Jenson, V. V Joshi, B. H. Pollock, R. T. Parmley, F. J DiCarlo, E G Chadick, and S. B. Murphy. 1995. Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS N. Engl J. Med. 332:12.
20. Lee, E. S., J. Locker, M. Nalesnik, J. Reyes, R. Jaffe, M. Alashari, B. Nour, A Tzakis, and P S. Dickman. 1995. The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N. Engl J Med 332.19.
21. Vaughan, J. H., M. D Nguyen, J. R. Valbracht, K. Patrick, and G H. Rhodes 1995 Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes: presence in autoimmune disease. J. Clin. Invest. 95:1316.
22. Bray, P. F., J. Luka, P. F. Bray, K. W. Culp, and J. P. Schlight 1992. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology 42:1798
23. Wucherpfennig, K. W , and J. L Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695.
24. Pedneault, L., B Z. Katz, and G. Miller. 1992 Detection of Epstein-Barr virus in the brain by the polymerase chain reaction. Ann. Neurol. 32:184
25. Bray, P. F., K. W. Culp, D. E. McFarlin, H. S Panitch, R. D. Torkelson, and J. P. Schlight. 1992. Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection Neurology 42:278.
26. Sebire, G., D. Emilie, C. Wallon, C. Hery, O. Devergne, J. F. Delfraissy, P. Galanaud, and M. Tardieu. 1993. In vitro production of IL-6, IL-1β, and tumor necrosis factor-α by human embryonic microglial and neuronal cells. J. Immunol 150:1517.
27. Gasque, P., P. Chan, M. Fontaine, A. Ischenko, M. Lamacz, O. Gotze, and B. P. Morgan. 1995. Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J. Immunol. 155:4882
28. Moore, M. D., N. R Cooper, B. F. Tack, and G. R. Nemerow. 1987. Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes Proc. Natl. Acad. Sci. USA 84:9194.
29. Toothaker, L. E. A. J. Henjes, and J J. Weiss. 1989. Variability of CR2 gene products is due to alternative exon usage and different CR2 alleles. J. Immunol. 142:3668.
30. Vedeler, C. A., and R. Matre. 1990. Peripheral nerve CR1 expresses in situ cofactor activity for degradation of C3b J Neuroimmunol. 26:51.
31. Lowell, C. A., L. B. Klickstein, R. H. Carter, J. A. Mitchell, D. T. Fearon, and J. M Ahearn. 1989 Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2. J. Exp. Med. 170:1931.
32. Carel, J C., B. L. Myones, B. Frazier, and V. M. Holers. 1990. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection. J. Biol. Chem. 265.12293.
33. Sinha, S. K. S. C. Todd, J. A Hedrick, C L. Speiser, J. D. Lambris, and C. D. Tsoukas. 1993. Characterization of the EBV/C3d receptor on the human Jurkat T cell line: evidence for a novel transcript J. Immunol. 150:5311.
34. Fearon, D. T , and R. H. Carter. 1995. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13.127.
35. Clapham, P. R , J. N Weber, D. Whitby, K McIntosh, A. G. Dalgleish, P. J. Maddon, K C. Deen, R. W. Sweet, and R. A. Weiss. 1989. Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature 337:368.
36. Ischenko, A. M., P. Gasque, M. T. Schouft, S. V. Andreev, T. D. Smirnova, and M. Fontaine. 1993. Characterization of a C1q receptor on human glioma cell lines. Mol. Immunol. 30:19 (Abstr)
37. Ischenko, A. M., P Gasque, S. Andreev, E. Sumereau, M. Lamacz, H. Vaudry, and M Fontaine. 1994. Characterization of a complement C3a receptor (C3aR) on astrocytes. J. Neuroimmunol. 54:159 (Abstr.).